Your browser doesn't support javascript.
loading
French updated recommendations in Stage I to III melanoma treatment and management.
Guillot, B; Dalac, S; Denis, M G; Dupuy, A; Emile, J F; De La Fouchardiere, A; Hindie, E; Jouary, T; Lassau, N; Mirabel, X; Piperno Neumann, S; De Raucourt, S; Vanwijck, R.
Affiliation
  • Guillot B; Dermatology Department, CHU Montpellier.
  • Dalac S; Dermatology Department, CHU Dijon.
  • Denis MG; Laboratory of Biochemistry, CHU Nantes.
  • Dupuy A; Dermatology Department, CHU Rennes.
  • Emile JF; Laboratory of Pathology, AP-HP Ambroise Paré Hospital, Boulogne, France.
  • De La Fouchardiere A; Laboratory of Pathology, Centre Léon Bérard Lyon.
  • Hindie E; Department of Nuclear medicine, CHU Bordeaux.
  • Jouary T; Dermatology Department, CH Pau.
  • Lassau N; Department of Radiology, Institut Gustave Roussy Villejuif.
  • Mirabel X; Department of Radiotherapy, Centre Oscar Lambret Lille.
  • Piperno Neumann S; Institut Curie, Paris, France.
  • De Raucourt S; 1 Avenue du 6 Juin, 1945, 14000 Caen, France.
  • Vanwijck R; Louvain Catholic University, Brussels, Belgium.
J Eur Acad Dermatol Venereol ; 31(4): 594-602, 2017 Apr.
Article in En | MEDLINE | ID: mdl-28120528
ABSTRACT
As knowledge continues to develop, regular updates are necessary concerning recommendations for practice. The recommendations for the management of melanoma stages I to III were drawn up in 2005. At the request of the Société Française de Dermatologie, they have now been updated using the methodology for recommendations proposed by the Haute Autorité de Santé in France. In practice, the principal recommendations are as follows for staging, it is recommended that the 7th edition of AJCC be used. The maximum excision margins have been reduced to 2 cm. Regarding adjuvant therapy, the place of interferon has been reduced and no validated emerging medication has yet been identified. Radiotherapy may be considered for patients in Stage III at high risk of relapse. The sentinel lymph node technique remains an option. Initial examination includes routine ultrasound as of Stage II, with other examinations being optional in stages IIC and III. A shorter strict follow-up period (3 years) is recommended for patients, but with greater emphasis on imaging.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Population Surveillance / Melanoma Type of study: Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies Country/Region as subject: Europa Language: En Journal: J Eur Acad Dermatol Venereol Journal subject: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Year: 2017 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Population Surveillance / Melanoma Type of study: Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies Country/Region as subject: Europa Language: En Journal: J Eur Acad Dermatol Venereol Journal subject: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Year: 2017 Type: Article